Repression of invasion genes and decreased invasion in a high-level fluoroquinolone-resistant Salmonella typhimurium mutant
Nalidixic acid resistance among Salmonella Typhimurium clinical isolates has steadily increased, whereas the level of ciprofloxacin resistance remains low. The main objective of this study was to characterize the fluoroquinolone resistance mechanisms acquired in a S. Typhimurium mutant selected with...
Saved in:
Published in | PloS one Vol. 4; no. 11; p. e8029 |
---|---|
Main Authors | , , , , |
Format | Journal Article |
Language | English |
Published |
United States
Public Library of Science
25.11.2009
Public Library of Science (PLoS) |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Nalidixic acid resistance among Salmonella Typhimurium clinical isolates has steadily increased, whereas the level of ciprofloxacin resistance remains low. The main objective of this study was to characterize the fluoroquinolone resistance mechanisms acquired in a S. Typhimurium mutant selected with ciprofloxacin from a susceptible isolate and to investigate its invasion ability.
Three different amino acid substitutions were detected in the quinolone target proteins of the resistant mutant (MIC of ciprofloxacin, 64 microg/ml): D87G and G81C in GyrA, and a novel mutation, E470K, in ParE. A protein analysis revealed an increased expression of AcrAB/TolC and decreased expression of OmpC. Sequencing of the marRAB, soxRS, ramR and acrR operons did not show any mutation and neither did their expression levels in a microarray analysis. A decreased percentage of invasion ability was detected when compared with the susceptible clinical isolate in a gentamicin protection assay. The microarray results revealed a decreased expression of genes which play a role during the invasion process, such as hilA, invF and the flhDC operon. Of note was the impaired growth detected in the resistant strain. A strain with a reverted phenotype (mainly concerning the resistance phenotype) was obtained from the resistant mutant.
In conclusion, a possible link between fluoroquinolone resistance and decreased cell invasion ability may exist explaining the low prevalence of fluoroquinolone-resistant S. Typhimurium clinical isolates. The impaired growth may appear as a consequence of fluoroquinolone resistance acquisition and down-regulate the expression of the invasion genes. |
---|---|
AbstractList | Background Nalidixic acid resistance among Salmonella Typhimurium clinical isolates has steadily increased, whereas the level of ciprofloxacin resistance remains low. The main objective of this study was to characterize the fluoroquinolone resistance mechanisms acquired in a S. Typhimurium mutant selected with ciprofloxacin from a susceptible isolate and to investigate its invasion ability. Methodology/Principal Findings Three different amino acid substitutions were detected in the quinolone target proteins of the resistant mutant (MIC of ciprofloxacin, 64 mg/ml): D87G and G81C in GyrA, and a novel mutation, E470K, in ParE. A protein analysis revealed an increased expression of AcrAB/TolC and decreased expression of OmpC. Sequencing of the marRAB, soxRS, ramR and acrR operons did not show any mutation and neither did their expression levels in a microarray analysis. A decreased percentage of invasion ability was detected when compared with the susceptible clinical isolate in a gentamicin protection assay. The microarray results revealed a decreased expression of genes which play a role during the invasion process, such as hilA, invF and the flhDC operon. Of note was the impaired growth detected in the resistant strain. A strain with a reverted phenotype (mainly concerning the resistance phenotype) was obtained from the resistant mutant. Conclusions/Significance In conclusion, a possible link between fluoroquinolone resistance and decreased cell invasion ability may exist explaining the low prevalence of fluoroquinolone-resistant S. Typhimurium clinical isolates. The impaired growth may appear as a consequence of fluoroquinolone resistance acquisition and down-regulate the expression of the invasion genes. Nalidixic acid resistance among Salmonella Typhimurium clinical isolates has steadily increased, whereas the level of ciprofloxacin resistance remains low. The main objective of this study was to characterize the fluoroquinolone resistance mechanisms acquired in a S. Typhimurium mutant selected with ciprofloxacin from a susceptible isolate and to investigate its invasion ability. Nalidixic acid resistance among Salmonella Typhimurium clinical isolates has steadily increased, whereas the level of ciprofloxacin resistance remains low. The main objective of this study was to characterize the fluoroquinolone resistance mechanisms acquired in a S. Typhimurium mutant selected with ciprofloxacin from a susceptible isolate and to investigate its invasion ability. Three different amino acid substitutions were detected in the quinolone target proteins of the resistant mutant (MIC of ciprofloxacin, 64 [micro]g/ml): D87G and G81C in GyrA, and a novel mutation, E470K, in ParE. A protein analysis revealed an increased expression of AcrAB/TolC and decreased expression of OmpC. Sequencing of the marRAB, soxRS, ramR and acrR operons did not show any mutation and neither did their expression levels in a microarray analysis. A decreased percentage of invasion ability was detected when compared with the susceptible clinical isolate in a gentamicin protection assay. The microarray results revealed a decreased expression of genes which play a role during the invasion process, such as hilA, invF and the flhDC operon. Of note was the impaired growth detected in the resistant strain. A strain with a reverted phenotype (mainly concerning the resistance phenotype) was obtained from the resistant mutant. In conclusion, a possible link between fluoroquinolone resistance and decreased cell invasion ability may exist explaining the low prevalence of fluoroquinolone-resistant S. Typhimurium clinical isolates. The impaired growth may appear as a consequence of fluoroquinolone resistance acquisition and down-regulate the expression of the invasion genes. Background Nalidixic acid resistance among Salmonella Typhimurium clinical isolates has steadily increased, whereas the level of ciprofloxacin resistance remains low. The main objective of this study was to characterize the fluoroquinolone resistance mechanisms acquired in a S. Typhimurium mutant selected with ciprofloxacin from a susceptible isolate and to investigate its invasion ability. Methodology/Principal Findings Three different amino acid substitutions were detected in the quinolone target proteins of the resistant mutant (MIC of ciprofloxacin, 64 µg/ml): D87G and G81C in GyrA, and a novel mutation, E470K, in ParE. A protein analysis revealed an increased expression of AcrAB/TolC and decreased expression of OmpC. Sequencing of the marRAB, soxRS, ramR and acrR operons did not show any mutation and neither did their expression levels in a microarray analysis. A decreased percentage of invasion ability was detected when compared with the susceptible clinical isolate in a gentamicin protection assay. The microarray results revealed a decreased expression of genes which play a role during the invasion process, such as hilA, invF and the flhDC operon. Of note was the impaired growth detected in the resistant strain. A strain with a reverted phenotype (mainly concerning the resistance phenotype) was obtained from the resistant mutant. Conclusions/Significance In conclusion, a possible link between fluoroquinolone resistance and decreased cell invasion ability may exist explaining the low prevalence of fluoroquinolone-resistant S. Typhimurium clinical isolates. The impaired growth may appear as a consequence of fluoroquinolone resistance acquisition and down-regulate the expression of the invasion genes. Background Nalidixic acid resistance among Salmonella Typhimurium clinical isolates has steadily increased, whereas the level of ciprofloxacin resistance remains low. The main objective of this study was to characterize the fluoroquinolone resistance mechanisms acquired in a S. Typhimurium mutant selected with ciprofloxacin from a susceptible isolate and to investigate its invasion ability. Methodology/Principal Findings Three different amino acid substitutions were detected in the quinolone target proteins of the resistant mutant (MIC of ciprofloxacin, 64 [micro]g/ml): D87G and G81C in GyrA, and a novel mutation, E470K, in ParE. A protein analysis revealed an increased expression of AcrAB/TolC and decreased expression of OmpC. Sequencing of the marRAB, soxRS, ramR and acrR operons did not show any mutation and neither did their expression levels in a microarray analysis. A decreased percentage of invasion ability was detected when compared with the susceptible clinical isolate in a gentamicin protection assay. The microarray results revealed a decreased expression of genes which play a role during the invasion process, such as hilA, invF and the flhDC operon. Of note was the impaired growth detected in the resistant strain. A strain with a reverted phenotype (mainly concerning the resistance phenotype) was obtained from the resistant mutant. Conclusions/Significance In conclusion, a possible link between fluoroquinolone resistance and decreased cell invasion ability may exist explaining the low prevalence of fluoroquinolone-resistant S. Typhimurium clinical isolates. The impaired growth may appear as a consequence of fluoroquinolone resistance acquisition and down-regulate the expression of the invasion genes. BackgroundNalidixic acid resistance among Salmonella Typhimurium clinical isolates has steadily increased, whereas the level of ciprofloxacin resistance remains low. The main objective of this study was to characterize the fluoroquinolone resistance mechanisms acquired in a S. Typhimurium mutant selected with ciprofloxacin from a susceptible isolate and to investigate its invasion ability.Methodology/principal findingsThree different amino acid substitutions were detected in the quinolone target proteins of the resistant mutant (MIC of ciprofloxacin, 64 microg/ml): D87G and G81C in GyrA, and a novel mutation, E470K, in ParE. A protein analysis revealed an increased expression of AcrAB/TolC and decreased expression of OmpC. Sequencing of the marRAB, soxRS, ramR and acrR operons did not show any mutation and neither did their expression levels in a microarray analysis. A decreased percentage of invasion ability was detected when compared with the susceptible clinical isolate in a gentamicin protection assay. The microarray results revealed a decreased expression of genes which play a role during the invasion process, such as hilA, invF and the flhDC operon. Of note was the impaired growth detected in the resistant strain. A strain with a reverted phenotype (mainly concerning the resistance phenotype) was obtained from the resistant mutant.Conclusions/significanceIn conclusion, a possible link between fluoroquinolone resistance and decreased cell invasion ability may exist explaining the low prevalence of fluoroquinolone-resistant S. Typhimurium clinical isolates. The impaired growth may appear as a consequence of fluoroquinolone resistance acquisition and down-regulate the expression of the invasion genes. Nalidixic acid resistance among Salmonella Typhimurium clinical isolates has steadily increased, whereas the level of ciprofloxacin resistance remains low. The main objective of this study was to characterize the fluoroquinolone resistance mechanisms acquired in a S. Typhimurium mutant selected with ciprofloxacin from a susceptible isolate and to investigate its invasion ability. Three different amino acid substitutions were detected in the quinolone target proteins of the resistant mutant (MIC of ciprofloxacin, 64 kg/ml): D87G and G81C in GyrA, and a novel mutation, E470K, in ParE. A protein analysis revealed an increased expression of AcrAB/TolC and decreased expression of OmpC. Sequencing of the marRAB, soxRS, ramR and acrR operons did not show any mutation and neither did their expression levels in a microarray analysis. A decreased percentage of invasion ability was detected when compared with the susceptible clinical isolate in a gentamicin protection assay. The microarray results revealed a decreased expression of genes which play a role during the invasion process, such as hilA, invF and the flhDC operon. Of note was the impaired growth detected in the resistant strain. A strain with a reverted phenotype (mainly concerning the resistance phenotype) was obtained from the resistant mutant. In conclusion, a possible link between fluoroquinolone resistance and decreased cell invasion ability may exist explaining the low prevalence of fluoroquinolone-resistant S. Typhimurium clinical isolates. The impaired growth may appear as a consequence of fluoroquinolone resistance acquisition and down-regulate the expression of the invasion genes. Background Nalidixic acid resistance among Salmonella Typhimurium clinical isolates has steadily increased, whereas the level of ciprofloxacin resistance remains low. The main objective of this study was to characterize the fluoroquinolone resistance mechanisms acquired in a S. Typhimurium mutant selected with ciprofloxacin from a susceptible isolate and to investigate its invasion ability. Methodology/Principal Findings Three different amino acid substitutions were detected in the quinolone target proteins of the resistant mutant (MIC of ciprofloxacin, 64 µg/ml): D87G and G81C in GyrA, and a novel mutation, E470K, in ParE. A protein analysis revealed an increased expression of AcrAB/TolC and decreased expression of OmpC. Sequencing of the marRAB, soxRS, ramR and acrR operons did not show any mutation and neither did their expression levels in a microarray analysis. A decreased percentage of invasion ability was detected when compared with the susceptible clinical isolate in a gentamicin protection assay. The microarray results revealed a decreased expression of genes which play a role during the invasion process, such as hilA, invF and the flhDC operon. Of note was the impaired growth detected in the resistant strain. A strain with a reverted phenotype (mainly concerning the resistance phenotype) was obtained from the resistant mutant. Conclusions/Significance In conclusion, a possible link between fluoroquinolone resistance and decreased cell invasion ability may exist explaining the low prevalence of fluoroquinolone-resistant S. Typhimurium clinical isolates. The impaired growth may appear as a consequence of fluoroquinolone resistance acquisition and down-regulate the expression of the invasion genes. Nalidixic acid resistance among Salmonella Typhimurium clinical isolates has steadily increased, whereas the level of ciprofloxacin resistance remains low. The main objective of this study was to characterize the fluoroquinolone resistance mechanisms acquired in a S. Typhimurium mutant selected with ciprofloxacin from a susceptible isolate and to investigate its invasion ability. Three different amino acid substitutions were detected in the quinolone target proteins of the resistant mutant (MIC of ciprofloxacin, 64 microg/ml): D87G and G81C in GyrA, and a novel mutation, E470K, in ParE. A protein analysis revealed an increased expression of AcrAB/TolC and decreased expression of OmpC. Sequencing of the marRAB, soxRS, ramR and acrR operons did not show any mutation and neither did their expression levels in a microarray analysis. A decreased percentage of invasion ability was detected when compared with the susceptible clinical isolate in a gentamicin protection assay. The microarray results revealed a decreased expression of genes which play a role during the invasion process, such as hilA, invF and the flhDC operon. Of note was the impaired growth detected in the resistant strain. A strain with a reverted phenotype (mainly concerning the resistance phenotype) was obtained from the resistant mutant. In conclusion, a possible link between fluoroquinolone resistance and decreased cell invasion ability may exist explaining the low prevalence of fluoroquinolone-resistant S. Typhimurium clinical isolates. The impaired growth may appear as a consequence of fluoroquinolone resistance acquisition and down-regulate the expression of the invasion genes. |
Audience | Academic |
Author | Fàbrega, Anna Le Bouguénec, Chantal du Merle, Laurence Jiménez de Anta, M Teresa Vila, Jordi |
AuthorAffiliation | 1 Department of Microbiology, Hospital Clínic, School of Medicine, University of Barcelona, Barcelona, Spain Charité-Universitätsmedizin Berlin, Germany 2 Institut Pasteur, Pathogénie Bactérienne des Muqueuses, Paris, France |
AuthorAffiliation_xml | – name: 2 Institut Pasteur, Pathogénie Bactérienne des Muqueuses, Paris, France – name: Charité-Universitätsmedizin Berlin, Germany – name: 1 Department of Microbiology, Hospital Clínic, School of Medicine, University of Barcelona, Barcelona, Spain |
Author_xml | – sequence: 1 givenname: Anna surname: Fàbrega fullname: Fàbrega, Anna organization: Department of Microbiology, Hospital Clínic, School of Medicine, University of Barcelona, Barcelona, Spain – sequence: 2 givenname: Laurence surname: du Merle fullname: du Merle, Laurence – sequence: 3 givenname: Chantal surname: Le Bouguénec fullname: Le Bouguénec, Chantal – sequence: 4 givenname: M Teresa surname: Jiménez de Anta fullname: Jiménez de Anta, M Teresa – sequence: 5 givenname: Jordi surname: Vila fullname: Vila, Jordi |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/19946377$$D View this record in MEDLINE/PubMed |
BookMark | eNqNk9tq3DAQhk1JaQ7tG5TWUEjpxaY6WbJuCiH0EAgEkra3QiuPdxVkaSPZoaEvX3nXTbKlpL0wlkbf_CP_49kvdnzwUBQvMTrCVOD3V2GIXrujVQ4fIYRqROSTYg9LSmacILrzYL1b7Kd0hVBFa86fFbtYSsapEHvFzwtYRUjJBl-GtrT-Rq_XC_CQSu2bsgETQSdo7g-tL3W5tIvlzMENuLJ1Q4jherA-uHybWRa0qde-Ly-163LEOV32t6ul7YZoh67shvH0efG01S7Bi-l9UHz79PHryZfZ2fnn05Pjs5mpCe9nglamMoKYRjTAsTS0ogzmc9YwJjDTojGMIAQgBJm3FKQ0tWmwwBI4waamB8Xrje7KhaQm35LCRBIsKypxJk43RBP0lVpF2-l4q4K2ah0IcaF07K1xoFpeZ7NZrVFL2BxANsZwyUWLK8w1gqz1Yao2zDtoDPg-arclun3i7VItwo0iQogKiSyANwImDUZFMBCN7teJd5vxIUgQRTiRePzEt1PRsQ-QetXZZEbfPYQhKcFY9oJS9G-SUlnXbK15-ChJcNZkkv8PSEVFR5vf_AH-vRnvNtRCZ7-tN8H38KNf6CEldXp5oY6ZIEKiTenH2PPv2-zhA3YJ2vXLFNzQ5186bYNsakAMKUVo75qHkRpn7_e11Th7apq9nPbqYePvk6Zho78A_MQuJQ |
CitedBy_id | crossref_primary_10_1093_jac_dkv410 crossref_primary_10_1016_j_ijmm_2010_02_003 crossref_primary_10_1093_jac_dkv299 crossref_primary_10_1292_jvms_12_0053 crossref_primary_10_1016_j_jiac_2016_05_004 crossref_primary_10_1080_21505594_2019_1596507 crossref_primary_10_1099_mic_0_001322 crossref_primary_10_1155_2014_718084 crossref_primary_10_1089_mdr_2017_0329 crossref_primary_10_1016_j_foodres_2011_06_015 crossref_primary_10_1089_fpd_2012_1216 crossref_primary_10_1089_mdr_2016_0024 crossref_primary_10_1093_jac_dkaa288 crossref_primary_10_1093_jac_dkr515 crossref_primary_10_3390_microorganisms10030579 crossref_primary_10_1016_j_ijantimicag_2013_08_017 crossref_primary_10_1089_mdr_2015_0158 crossref_primary_10_1038_s41598_017_09151_y crossref_primary_10_3390_antibiotics11010053 crossref_primary_10_1128_CMR_00066_12 crossref_primary_10_1097_INF_0000000000001652 crossref_primary_10_1093_jac_dku078 crossref_primary_10_1128_AAC_05136_14 crossref_primary_10_1016_j_rvsc_2015_05_004 crossref_primary_10_1016_j_eimc_2016_08_001 crossref_primary_10_1111_jam_12924 crossref_primary_10_7554_eLife_01229 crossref_primary_10_1111_j_1574_6968_2012_02577_x crossref_primary_10_4315_0362_028x_12_101 crossref_primary_10_1021_pr100906v crossref_primary_10_1186_s13756_017_0171_6 crossref_primary_10_1186_s12866_020_01886_5 crossref_primary_10_1093_femspd_ftaa011 crossref_primary_10_1371_journal_pntd_0008732 crossref_primary_10_1038_s41598_017_15369_7 |
ContentType | Journal Article |
Contributor | Universitat de Barcelona |
Contributor_xml | – sequence: 1 fullname: Universitat de Barcelona |
Copyright | COPYRIGHT 2009 Public Library of Science 2009 Fábrega et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. cc-by (c) Fábregas, A. et al., 2009 info:eu-repo/semantics/openAccess http://creativecommons.org/licenses/by/3.0/es Fábrega et al. 2009 |
Copyright_xml | – notice: COPYRIGHT 2009 Public Library of Science – notice: 2009 Fábrega et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. – notice: cc-by (c) Fábregas, A. et al., 2009 info:eu-repo/semantics/openAccess <a href="http://creativecommons.org/licenses/by/3.0/es">http://creativecommons.org/licenses/by/3.0/es</a> – notice: Fábrega et al. 2009 |
DBID | CGR CUY CVF ECM EIF NPM AAYXX CITATION IOV ISR 3V. 7QG 7QL 7QO 7RV 7SN 7SS 7T5 7TG 7TM 7U9 7X2 7X7 7XB 88E 8AO 8C1 8FD 8FE 8FG 8FH 8FI 8FJ 8FK ABJCF ABUWG AFKRA ARAPS ATCPS AZQEC BBNVY BENPR BGLVJ BHPHI C1K CCPQU D1I DWQXO FR3 FYUFA GHDGH GNUQQ H94 HCIFZ K9. KB. KB0 KL. L6V LK8 M0K M0S M1P M7N M7P M7S NAPCQ P5Z P62 P64 PATMY PDBOC PIMPY PQEST PQQKQ PQUKI PTHSS PYCSY RC3 7X8 XX2 5PM DOA |
DOI | 10.1371/journal.pone.0008029 |
DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed CrossRef Gale In Context: Opposing Viewpoints Gale In Context: Science ProQuest Central (Corporate) Animal Behavior Abstracts Bacteriology Abstracts (Microbiology B) Biotechnology Research Abstracts ProQuest Nursing and Allied Health Journals Ecology Abstracts Entomology Abstracts (Full archive) Immunology Abstracts Meteorological & Geoastrophysical Abstracts Nucleic Acids Abstracts Virology and AIDS Abstracts Agricultural Science Collection PHMC-Proquest健康医学期刊库 ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) ProQuest Pharma Collection ProQuest Public Health Database Technology Research Database ProQuest SciTech Collection ProQuest Technology Collection ProQuest Natural Science Collection Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) Materials Science & Engineering Database (Proquest) ProQuest Central (Alumni) ProQuest Central UK/Ireland Advanced Technologies & Aerospace Database (1962 - current) Agricultural & Environmental Science Collection ProQuest Central Essentials Biological Science Collection AUTh Library subscriptions: ProQuest Central Technology Collection ProQuest Natural Science Collection Environmental Sciences and Pollution Management ProQuest One Community College ProQuest Materials Science Collection ProQuest Central Engineering Research Database Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Central Student AIDS and Cancer Research Abstracts SciTech Premium Collection ProQuest Health & Medical Complete (Alumni) https://resources.nclive.org/materials Nursing & Allied Health Database (Alumni Edition) Meteorological & Geoastrophysical Abstracts - Academic ProQuest Engineering Collection Biological Sciences Agriculture Science Database Health & Medical Collection (Alumni Edition) PML(ProQuest Medical Library) Algology Mycology and Protozoology Abstracts (Microbiology C) Biological Science Database ProQuest Engineering Database Nursing & Allied Health Premium ProQuest Advanced Technologies & Aerospace Database ProQuest Advanced Technologies & Aerospace Collection Biotechnology and BioEngineering Abstracts Environmental Science Database Materials Science Collection ProQuest - Publicly Available Content Database ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition Engineering Collection Environmental Science Collection Genetics Abstracts MEDLINE - Academic Recercat PubMed Central (Full Participant titles) DOAJ Directory of Open Access Journals |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) CrossRef Agricultural Science Database Publicly Available Content Database ProQuest Central Student ProQuest Advanced Technologies & Aerospace Collection ProQuest Central Essentials Nucleic Acids Abstracts SciTech Premium Collection Environmental Sciences and Pollution Management Health Research Premium Collection Meteorological & Geoastrophysical Abstracts Natural Science Collection Biological Science Collection ProQuest Medical Library (Alumni) Engineering Collection Advanced Technologies & Aerospace Collection Engineering Database Virology and AIDS Abstracts ProQuest Biological Science Collection ProQuest One Academic Eastern Edition Agricultural Science Collection ProQuest Hospital Collection ProQuest Technology Collection Health Research Premium Collection (Alumni) Biological Science Database Ecology Abstracts ProQuest Hospital Collection (Alumni) Biotechnology and BioEngineering Abstracts Environmental Science Collection Entomology Abstracts Nursing & Allied Health Premium ProQuest Health & Medical Complete ProQuest One Academic UKI Edition Environmental Science Database ProQuest Nursing & Allied Health Source (Alumni) Engineering Research Database ProQuest One Academic Meteorological & Geoastrophysical Abstracts - Academic Technology Collection Technology Research Database Materials Science Collection ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest Natural Science Collection ProQuest Pharma Collection ProQuest Central Genetics Abstracts ProQuest Engineering Collection Biotechnology Research Abstracts Health and Medicine Complete (Alumni Edition) ProQuest Central Korea Bacteriology Abstracts (Microbiology B) Algology Mycology and Protozoology Abstracts (Microbiology C) Agricultural & Environmental Science Collection AIDS and Cancer Research Abstracts Materials Science Database ProQuest Materials Science Collection ProQuest Public Health ProQuest Nursing & Allied Health Source ProQuest SciTech Collection Advanced Technologies & Aerospace Database ProQuest Medical Library Animal Behavior Abstracts Materials Science & Engineering Collection Immunology Abstracts ProQuest Central (Alumni) MEDLINE - Academic |
DatabaseTitleList | Genetics Abstracts Genetics Abstracts Bacteriology Abstracts (Microbiology B) MEDLINE - Academic Agricultural Science Database MEDLINE |
Database_xml | – sequence: 1 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 4 dbid: 8FG name: ProQuest Technology Collection url: https://search.proquest.com/technologycollection1 sourceTypes: Aggregation Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Sciences (General) |
DocumentTitleAlternate | Invasion-Quinolone Resistance |
EISSN | 1932-6203 |
Editor | Bereswill, Stefan |
Editor_xml | – sequence: 1 givenname: Stefan surname: Bereswill fullname: Bereswill, Stefan |
EndPage | e8029 |
ExternalDocumentID | 1292195391 oai_doaj_org_article_f6800048a0f24bee9dcc6967f1516a0e oai_recercat_cat_2072_262918 2898410381 A472790496 10_1371_journal_pone_0008029 19946377 |
Genre | Research Support, Non-U.S. Gov't Journal Article |
GeographicLocations | France |
GeographicLocations_xml | – name: France |
GroupedDBID | --- 123 29O 2WC 3V. 53G 5VS 7RV 7X2 7X7 7XC 88E 8AO 8C1 8CJ 8FE 8FG 8FH 8FI 8FJ A8Z AAFWJ ABDBF ABIVO ABJCF ABUWG ACGFO ACIHN ACIWK ACPRK ADBBV ADRAZ AEAQA AENEX AFKRA AFPKN AFRAH AHMBA ALIPV ALMA_UNASSIGNED_HOLDINGS AOIJS APEBS ARAPS ATCPS BAWUL BBNVY BBORY BCNDV BENPR BGLVJ BHPHI BKEYQ BPHCQ BVXVI BWKFM CCPQU CGR CS3 CUY CVF D1I D1J D1K DIK DU5 E3Z EAP EAS EBD ECM EIF EMOBN ESTFP ESX EX3 F5P FPL FYUFA GROUPED_DOAJ GX1 HCIFZ HH5 HMCUK HYE IAO IEA IHR IHW INH INR IOV IPY ISE ISR ITC K6- KB. KQ8 L6V LK5 LK8 M0K M1P M48 M7P M7R M7S M~E NAPCQ NPM O5R O5S OK1 P2P P62 PATMY PDBOC PIMPY PQQKQ PROAC PSQYO PTHSS PYCSY RNS RPM SV3 TR2 UKHRP WOQ WOW ~02 ~KM AAYXX CITATION 7QG 7QL 7QO 7SN 7SS 7T5 7TG 7TM 7U9 7XB 8FD 8FK AZQEC C1K DWQXO FR3 GNUQQ H94 K9. KL. M7N P64 PQEST PQUKI RC3 7X8 XX2 5PM AAPBV ABPTK N95 |
ID | FETCH-LOGICAL-c826t-735c5c72cd7de619c3534ebb4d44714a7dc4200ee772bf3e99c8cd1719e621c83 |
IEDL.DBID | RPM |
ISSN | 1932-6203 |
IngestDate | Sun Apr 02 01:15:47 EDT 2023 Fri Jul 05 11:39:13 EDT 2024 Tue Sep 17 20:59:45 EDT 2024 Fri Oct 04 12:24:06 EDT 2024 Fri Aug 16 20:59:38 EDT 2024 Sat Aug 17 02:55:11 EDT 2024 Fri Jun 28 14:55:18 EDT 2024 Thu Jul 25 11:59:39 EDT 2024 Mon Oct 07 12:39:11 EDT 2024 Thu Aug 01 19:23:31 EDT 2024 Thu Aug 01 19:41:47 EDT 2024 Tue Aug 20 22:04:35 EDT 2024 Fri Aug 23 00:54:34 EDT 2024 Tue Aug 27 13:45:16 EDT 2024 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 11 |
Language | English |
License | This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited. Creative Commons Attribution License |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c826t-735c5c72cd7de619c3534ebb4d44714a7dc4200ee772bf3e99c8cd1719e621c83 |
Notes | ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-Feature-1 content type line 23 ObjectType-Article-1 ObjectType-Feature-2 Current address: Institut Pasteur, Biologie des Bactéries Pathogènes à Gram positif, Paris, France Conceived and designed the experiments: LdM CLB JV. Performed the experiments: AF. Analyzed the data: MTJdA. Wrote the paper: AF JV. |
OpenAccessLink | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2777507/ |
PMID | 19946377 |
PQID | 1292195391 |
PQPubID | 23462 |
PageCount | e8029 |
ParticipantIDs | plos_journals_1292195391 doaj_primary_oai_doaj_org_article_f6800048a0f24bee9dcc6967f1516a0e pubmedcentral_primary_oai_pubmedcentral_nih_gov_2777507 csuc_recercat_oai_recercat_cat_2072_262918 proquest_miscellaneous_744621330 proquest_miscellaneous_733988418 proquest_miscellaneous_21462496 proquest_miscellaneous_21437531 proquest_journals_1292195391 gale_incontextgauss_ISR_A472790496 gale_incontextgauss_IOV_A472790496 gale_healthsolutions_A472790496 crossref_primary_10_1371_journal_pone_0008029 pubmed_primary_19946377 |
PublicationCentury | 2000 |
PublicationDate | 2009-11-25 |
PublicationDateYYYYMMDD | 2009-11-25 |
PublicationDate_xml | – month: 11 year: 2009 text: 2009-11-25 day: 25 |
PublicationDecade | 2000 |
PublicationPlace | United States |
PublicationPlace_xml | – name: United States – name: San Francisco – name: San Francisco, USA |
PublicationTitle | PloS one |
PublicationTitleAlternate | PLoS One |
PublicationYear | 2009 |
Publisher | Public Library of Science Public Library of Science (PLoS) |
Publisher_xml | – name: Public Library of Science – name: Public Library of Science (PLoS) |
References | 11104815 - Microbiol Mol Biol Rev. 2000 Dec;64(4):694-708 12523625 - Microb Drug Resist. 2002 Winter;8(4):281-9 2679373 - Antimicrob Agents Chemother. 1989 Aug;33(8):1318-25 17208038 - Curr Opin Microbiol. 2007 Feb;10(1):24-9 2830029 - Cell. 1988 Feb 26;52(4):569-84 8891148 - Antimicrob Agents Chemother. 1996 Oct;40(10):2380-6 15765061 - J Microbiol. 2005 Feb;43 Spec No:85-92 21261881 - Microb Biotechnol. 2009 Jan;2(1):40-61 17040923 - J Antimicrob Chemother. 2006 Dec;58(6):1274-8 15765064 - J Microbiol. 2005 Feb;43 Spec No:110-7 19124574 - J Bacteriol. 2009 Mar;191(6):1855-67 2821125 - J Infect Dis. 1987 Nov;156(5):751-7 9317011 - Infect Immun. 1997 Oct;65(10):4082-9 15942878 - Clin Infect Dis. 2005 Jul 15;41 Suppl 2:S120-6 16141278 - J Antimicrob Chemother. 2005 Oct;56(4):619-23 19104017 - Antimicrob Agents Chemother. 2009 Mar;53(3):1080-7 18308515 - Int J Antimicrob Agents. 2008 Apr;31(4):307-15 9537377 - J Bacteriol. 1998 Apr;180(7):1793-802 8637919 - Proc Natl Acad Sci U S A. 1996 Mar 19;93(6):2593-7 10742687 - Microbes Infect. 2000 Feb;2(2):145-56 15213159 - Infect Immun. 2004 Jul;72(7):4138-50 8817493 - Mol Microbiol. 1995 Nov;18(4):715-27 18443112 - Antimicrob Agents Chemother. 2008 Jul;52(7):2428-34 19474201 - Genetics. 2009 Aug;182(4):1183-95 3035573 - Proc Natl Acad Sci U S A. 1987 Jun;84(12):4185-9 10471553 - Antimicrob Agents Chemother. 1999 Sep;43(9):2131-7 8385664 - J Bacteriol. 1993 Apr;175(8):2229-35 10438766 - J Bacteriol. 1999 Aug;181(16):4949-54 8550435 - J Bacteriol. 1996 Jan;178(1):306-8 17043131 - Antimicrob Agents Chemother. 2007 Feb;51(2):535-42 18160484 - Infect Immun. 2008 Mar;76(3):1024-35 9311997 - EMBO J. 1997 Sep 1;16(17):5376-85 15848289 - Int J Antimicrob Agents. 2005 May;25(5):358-73 2171779 - Cell. 1990 Nov 2;63(3):631-42 2548211 - Proc Natl Acad Sci U S A. 1989 Aug;86(16):6383-7 11302812 - Antimicrob Agents Chemother. 2001 May;45(5):1467-72 15336432 - FEMS Microbiol Lett. 2004 Sep 1;238(1):267-72 9786194 - Mol Microbiol. 1998 Oct;30(1):175-88 15388468 - Antimicrob Agents Chemother. 2004 Oct;48(10):4012-5 15673791 - Antimicrob Agents Chemother. 2005 Feb;49(2):862-3 16045614 - Mol Microbiol. 2005 Aug;57(3):691-705 16406778 - Curr Opin Microbiol. 2006 Feb;9(1):46-54 15388427 - Antimicrob Agents Chemother. 2004 Oct;48(10):3729-35 17146467 - Immunol Cell Biol. 2007 Feb-Mar;85(2):112-8 12631974 - Euro Surveill. 2003 Feb;8(2):41-5 2160435 - Infect Immun. 1990 Jun;58(6):1879-85 11170916 - Clin Infect Dis. 2001 Jan 15;32(2):263-9 17088493 - Antimicrob Agents Chemother. 2007 Jan;51(1):195-7 17635868 - Infect Immun. 2007 Oct;75(10):4697-709 18762392 - Vet Microbiol. 2009 Feb 2;133(4):328-34 18366323 - Microb Drug Resist. 2008 Mar;14(1):31-5 |
References_xml | |
SSID | ssj0053866 |
Score | 2.2131906 |
Snippet | Nalidixic acid resistance among Salmonella Typhimurium clinical isolates has steadily increased, whereas the level of ciprofloxacin resistance remains low. The... Background Nalidixic acid resistance among Salmonella Typhimurium clinical isolates has steadily increased, whereas the level of ciprofloxacin resistance... BACKGROUNDNalidixic acid resistance among Salmonella Typhimurium clinical isolates has steadily increased, whereas the level of ciprofloxacin resistance... BackgroundNalidixic acid resistance among Salmonella Typhimurium clinical isolates has steadily increased, whereas the level of ciprofloxacin resistance... Background Nalidixic acid resistance among Salmonella Typhimurium clinical isolates has steadily increased, whereas the level of ciprofloxacin resistance... |
SourceID | plos doaj pubmedcentral csuc proquest gale crossref pubmed |
SourceType | Open Website Open Access Repository Aggregation Database Index Database |
StartPage | e8029 |
SubjectTerms | Acid resistance Acids Amino acids Analysis Anti-Bacterial Agents - pharmacology Antibiotics Chromosomes Ciprofloxacin Ciprofloxacin - pharmacology Clinical isolates Deoxyribonucleic acid DNA DNA microarrays DNA topoisomerase IV Drug resistance Drug Resistance, Bacterial E coli Escherichia coli Expressió gènica Fluoroquinolones - pharmacology Gene expression Gene Expression Regulation, Bacterial Gene silencing Genes Genetic research Genomes Genotype & phenotype Gentamicin HeLa Cells Humans Infectious Diseases/Antimicrobials and Drug Resistance Infectious Diseases/Gastrointestinal Infections Microbial drug resistance Microbiology/Medical Microbiology Models, Genetic Mutació (Biologia) Mutation Mutation (Biology) Nalidixic acid Nalidixic Acid - pharmacology Neoplasm Invasiveness Operons Phenotype Physiology Polymerase chain reaction Proteins Reacció en cadena de la polimerasa Resistant mutant Resistència als medicaments Reverse Transcriptase Polymerase Chain Reaction Salmonella Salmonella Typhimurium Salmonella typhimurium - genetics Salmonel·la Target detection Transcription, Genetic |
SummonAdditionalLinks | – databaseName: DOAJ Directory of Open Access Journals dbid: DOA link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3db9MwELdQn3hBjK-FDWYhHgApW2I7dvw4ENNAAqSNob1ZiT-2SK1bNQkS4p_n7KTdijbggYdKbe7q1L7z3e_quwtCLwWpKXekSLnLspRJ7dKqyGlqSkcLqQU1sSrt02d-fMY-nhfn1x71FXLChvbAw8IdOF7Gwucqc4TV1kqjNZdcOHBVvMpstL55sQqmBhsMu5jzsVCOivxglMv-Yu7t_lBfKjcc0US3vR7b9q-N82Qxnbc3Ic_fEyiveaSj--jeCCXx4TCFLXTH-gdoa9ysLX41dpR-_RD9PFnlu3o8d7jx36v4_iIYOlx5g01Ej601V8TG4wqHbsbpNCQWYTft5-EnNuGfeG9TGDBgT9_h02oKyhzSqHD3Y3HZzPpl08_wrA_UR-js6P3Xd8fp-NSFVEOo0aWCFrrQgmgjjIXwStOCMlvXzDBwZKwSRjPYWtYCLq8dtVLqUptc5NJykuuSPkYTDzfdRhjE4wBTAURy8MWSScCHEJHKgjnQHJEnKF2JQC2G5hoqnrAJCEqGRVRBZGoUWYLeBDkp8AV2qatOhd7Y6w_hRTJBFOFE5mWC3gZprgcOvPECaJcatUv9TbsStBd0QQ1FqWtroA4ZTEpCdMUT9CJyhF4aPiTrXFR926oPX779A9PpyQbTdlC41cxbBVCMhFNOCQu1u1LCm8l7azJYh3DkU3k771tFAA5DQPpnDk7i3fEtHIJSWZYsrOitLAwGySnNEvRk2BlX8pSScSpEgsTGntmQyybFN5exzzkRAvCsePo_BLmD7sZzwDxPSbGLJt2yt88ATnb182g5fgEUFXXE priority: 102 providerName: Directory of Open Access Journals – databaseName: ProQuest Public Health Database dbid: 8C1 link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV3db9MwELdGeeEFMb4WGMxCPABS1vojdvyExqDaEAOpY2hvVuI4W6UuKU3DC_88d_loKdomHiq18TWxcx_-nX13JuS15qlQOY9ClY9GoTQuD5OIiTCLcxEZp0XWZKWdfFVHZ_LzeXS-RY76XBgMq-xtYmOos9LhGvkQ5iWOWz6GDZMUVwHccvh-_jPE86Nwn7U7TOMOuctARPEQh_hwFewBWq1UlzgnNBt2fNqfl4Xfb_NNzcbENHBV7boy_itjPZjPyuo6JPpvQOVfM9T4AbnfQUt60MrCNtnyxUOy3SlvRd90FabfPiK_J338a0HLnB4Xv5LmO1JUNCky-rFBk5XP1o3TgiYUw0LCLxhoRMezusQuTnFlvvDhxFeIRYslPU1m8I4wrIqCm3s5vaoX0_qKntTY-picjT99PzwKu1MYQgeuxzLUInKR09xlOvPgbjkRCenTVGYSJjaZ6MxJUDXvAaenufDGuNhlTDPjFWcuFk_IoICH7hCajHwOGAsgUw5_jKUBvAgeqolkDpKkWUDCngV23hbbsM2OmwYnpX2JFllmO5YF5B3yycLc4BcuWVqslb36gR8-0txyxQ2LA_IBubm6MdI2F8rFhe3U1OYqbtLsk1HOZeq9yZxTRkF_I6ag-wHZQ1mwbZLqyjrYAwmDMuBtqYC8aiiwtkaBwTsXSV1V9vjbj_8gOp1sEO2gwPUjr-xaBQKy2wvh9c17q2awFrgFlBS-rCvLAR6Dg3o7heLN0-kNFFoIE8cS3-iNJBJuwoQYBeRpqxlrfhojldA6IHpDZzb4stlSTC-buudca8C3-tntg39O7jU7foyFPNolg-Wi9i8AOC7Tl41N-AOl0G9u priority: 102 providerName: ProQuest – databaseName: Scholars Portal Open Access Journals dbid: M48 link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV3db9MwELdGeeEFMb6WMZiFeACkTI3t2PEDQuOj2hAFqaNob1biOFulzilNg0D885ydj1HUIh4qtblz4vju7N_Vd2eEngmSUV6QOOTFcBgyqYswjSMa5klBY6kFzX1W2vgTP5myD-fx-Q7qzmxtB7Da6Nq586Smy_nRj28_X4PBv_KnNoioa3S0KK05arJH5Q10kzDKnM6PWb-vANbNeZtAt63l2gI10FWt23L-_aQ9WMzLahMi_Tuw8o-VanQH3W4hJj5udGIX7Rh7F-22Rlzh522l6Rf30K9JFwdrcVngU_s99d8dR4VTm-N3HlVWJr8mzixOsQsPCT-6gCM8mtel6-LM_UNvTTgxlcOkdoXP0jkouQuvwuDuXs6u6uWsvsLj2lHvo-no_Ze3J2F7GkOowQVZhYLGOtaC6FzkBtwuTWPKTJaxnMECx1KRawYmZwzg9aygRkqd6DwSkTScRDqhD9DAwkP3EE6HpgCsBdCpgIYJk4AbwVOVMStAo0QUoLATgVo0RTeU33kT4Kw0g6icyFQrsgC9dHJSsEaYpU5XytXM7n-4DxkKoggnMkoC9MZJs7-x4_UXyuWFas1VFTzx6fbpsCAsM0bmWnPJob9xxKH7ATp0uqCaZNV-llDHDF5KgtfFA_TUc7gaG9YF8VykdVWp089f_4PpbLLGtOcUrnvzSgFEI273U8JAHXRKuJl82JNh1nBbQak1ZV0pAjAZHNV_c3Din463cAhKZZIwN6JbWRjcJKJ0GKCHjWVcy1NKxqkQARJrNrMml3WKnV36-udECMC5Yn_7uDxCt_yuXxSFJD5Ag9WyNo8BPK6yJ34--A2VRW_5 priority: 102 providerName: Scholars Portal |
Title | Repression of invasion genes and decreased invasion in a high-level fluoroquinolone-resistant Salmonella typhimurium mutant |
URI | https://www.ncbi.nlm.nih.gov/pubmed/19946377 https://www.proquest.com/docview/1292195391/abstract/ https://search.proquest.com/docview/21437531 https://search.proquest.com/docview/21462496 https://search.proquest.com/docview/733988418 https://search.proquest.com/docview/744621330 https://recercat.cat/handle/2072/262918 https://pubmed.ncbi.nlm.nih.gov/PMC2777507 https://doaj.org/article/f6800048a0f24bee9dcc6967f1516a0e http://dx.doi.org/10.1371/journal.pone.0008029 |
Volume | 4 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3Nb9MwFLdGuXBBjK8FRmchDoCUtrEdOz5uY2VDdEwdQ7tZieNslVq3ahouSPztPDtJR9GGEIdaTf2SOH4f_r34vVeE3giSUV6QOOTFYBAyqYswjSMa5klBY6kFzX1W2uiUH1-wT5fx5RaK21wYH7Svs0nPTmc9O7n2sZWLme63cWL9s9EhEQIWOtG_h-4JSlsXvTa_oMCcNzlyVET9hiW9xdyaXp1aWlcKlYxTITaWo44uK90U71-b6M5iOi9vw59_hlH-ti4NH6GHDaDE-_XAt9GWsY_RdqOyJX7b1JV-9wT9GLdRrxbPC3xiv6f-u6MocWpz_MFjyNLkN50Ti1PsgkHCzy68CA-n1dwNceLex1sTjk3pEKhd4fN0CiLtgqkwOLfXk1m1nFQzPKpc71N0MTz6engcNv-9EGpwOFahoLGOtSA6F7kBJ0vTmDKTZSxnsJyxVOSagYIZA-g8K6iRUic6j0QkDSeRTugz1LFw0x2E04EpAFkBUCrgxIRJQIngl8qYFSA_IgpQ2LJALeoSG8rvswlwTepJVI57quFegN47PilYEcxSpyvlKmSvD9yHDARRhBMZJQE6cNxcX9jR-h_myyvVyJQqeOKT69NBQVhmjMy15pLDeOOIw_ADtOdkQdWpqWuboPYZPJQEH4sH6LWncBU1rAvZuUqrslQnX779A9H5eINoxwlc--SlAkBG3F6nhInabYXw9u69dTfYCLfxk1ozr0pFABSDW_p3Ck783fEdFKBoMkmYm9E7SRhcJKJ0EKDntWbc8LNRtwCJDZ3Z4MtmDyi_r3beKPuL_z7zJXrgtwCjKCTxLuqslpV5BUhylXXBflwKaJPDyLXDj110_-Do9Gzc9e9moB2xxLU_j7reyvwCa1F8LQ |
link.rule.ids | 230,315,733,786,790,870,891,2115,2236,12083,12250,12792,21416,24346,27957,27958,31754,31755,33301,33302,33408,33409,33779,33780,43345,43614,43635,43840,53827,53829,74102,74371,74392,74659 |
linkProvider | National Library of Medicine |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjR1Nb9Mw1IJygAtifC0wqIU4AFK2xnbs-ITGoGqhHVK3od2s1HG2Sl1SmoYLf573kjSlaJs4VErjl8T2-7bfeybkrWJTLlMW-jLt9XyhberHYcD9JEp5qK3iSZWVNj6WgzPx9Tw8bxbciiasci0TK0Gd5BbXyA9ALzHc8tHBx8VPH0-Nwt3V5giNu-Se4KBoMFP8qA3xAF6WskmX4yo4aLCzv8gzt19nmeotddSxRWmb4v2tiO4s5nlxnf35bxjlX3qp_4g8bAxKelhTwA6547LHZKdh2YK-a-pKv39Cfk_WUa8ZzVM6zH7F1TVCFDTOEvq5siELl2waZxmNKQaD-CMML6L9eZljF2e4Hp85f-IKtECzFT2J5zBHGExFwbm9nF2Vy1l5Rccltj4lZ_0vp0cDvzl7wbfgcKx8xUMbWsVsohIHTpblIRduOhWJAHUmYpVYAQzmHFjn05Q7rW1kk0AF2kkW2Ig_I50MPrpLaNxzKVhWYCil8GAkNFiJ4JfqUKRAPyrwiL9GgVnUJTZMtc-mwDWpJ9EgykyDMo98QDwZ0AhuaeOVwQrZ7R_8sZ5ihkmmg8gjnxCb7YsRtrqRLy9Mw5wmlVGVXB_3UiamzunEWqkl9DcMJHTfI12kBVOnprYywRwKGJQGH0t65E0FgRU1MgzZuYjLojDD7z_-A-hksgW0iwS3HnlhNoTvkb01EV7f3G2bQUbgxk-cubwsDAOjGNzS2yEkq75Ob4BQnOsoEjijN4IIeEnAec8jz2vO2OBTayG5Uh5RWzyzhZftlmx2WVU7Z0qBVate3D74Lrk_OB2PzGh4_O0leVDt-eHiv9wjndWydK_AdFxNX1fy4Q8a8G6j |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV3db9MwELegSIgXxPhaYFAL8QBIWRPbseMnNBhlhW2gjU17s1LH2Sp1SWkaXvjnuUvdlqJt4qFSG18T2_f1u_h8JuS1YkMuC5aEsoiiUGhbhFkS8zBPC55oq3je7ko7OJR7J-LLWXLm859qn1a5sImtoc4ri-_Ie-CXGC756LhX-LSI77v995OfIZ4ghSut_jiN2-QOgmw8zSDtf15YZdBrKf3WOa7inufU9qQq3fZ8x6lec00dWzfWF_JfmuvOZFzVV2HRf1Mq__JR_QfkvgeXdGcuDRvklisfkg2vvjV942tMv31Efh8tMmBLWhV0UP7K2u9IUdOszOluiydrl68aRyXNKCaGhPuYakT746bCLo7w3XzpwiNXIxotZ_Q4G8McYWIVhUD3YnTZTEfNJT1osPUxOel_-vFxL_TnMIQWgo9ZqHhiE6uYzVXuIOCyPOHCDYciF-DaRKZyK0DZnAOkPiy409qmNo9VrJ1ksU35E9Ip4aGbhGaRKwBlAWgq4I-p0IAYIUbViShAllQckHDBAjOZl9sw7ZqbgjBlPokGWWY8ywLyDvlkwDu4qc1mBqtlL3_gh0WKGSaZjtOAfEBuLm-MtO2FanpuvKKaQqbtRvssKpgYOqdza6WW0N8kltD9gHRRFsx8m-rSPpgdAYPSEG_JgLxqKbC6Rolyep41dW0G307_g-j4aI1oEwVuMfLarJQgIFsLIby6ubtsBnuBi0BZ6aqmNgwAMoSoN1NI1j6dXkOhONdpKnBGryURcJOY8yggT-easeKn1kJypQKi1nRmjS_rLeXooq18zpQChKue3Tz4LrkLpsHsDw6_Pif32uW_OA5ZskU6s2njXgCKnA1ftubhD-h1cw4 |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Repression+of+Invasion+Genes+and+Decreased+Invasion+in+a+High-Level+Fluoroquinolone-Resistant+Salmonella+Typhimurium+Mutant&rft.jtitle=PloS+one&rft.au=F%C3%A0brega%2C+Anna&rft.au=Laurence+du+Merle&rft.au=Chantal+Le+Bougu%C3%A9nec&rft.au=M+Teresa+Jim%C3%A9nez+de+Anta&rft.date=2009-11-25&rft.pub=Public+Library+of+Science&rft.eissn=1932-6203&rft.volume=4&rft.issue=11&rft_id=info:doi/10.1371%2Fjournal.pone.0008029&rft.externalDocID=1292195391 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1932-6203&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1932-6203&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1932-6203&client=summon |